Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 2 N=357 Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Chronic Hepatitis C
Primary: Percent of Participants Who Were Hepatitis C Virus Ribonucleic Acid (HCV-RNA) Negative at the End of Treatment (EoT) — 35.0; 6.3; 16.3; 13.4 Percent of participants
Merck Sharp & Dohme LLC Results Dec 2011 6.0% serious AE View details

Phase 2 N=21 Beta-Cell Function and Sitagliptin Trial (BEST)

Type 2 Diabetes Mellitus
Primary: Preservation of Beta-cell Function Measured by Area-under-the-curve (C-peptide/Glucose)/HOMA-IR — 80.4; 71.2 index of beta-cell function
Samuel Lunenfeld Research Institute, Mount Sinai… Results Dec 2011 9.5% serious AE View details